Live Breaking News & Updates on Antiplatelet Agent Related Bleeding

Stay updated with breaking news from Antiplatelet agent related bleeding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dropping Aspirin Cuts Bleeding in LVAD Patients

A randomized trial evaluating vitamin K therapy with aspirin or placebo with a left ventricular assist device shows avoiding aspirin reduced bleeding without increasing thrombotic risk. ....

United States , Mandeep Mehra , Eric David Adler , Vascular Center , American Heart Association , University Of California San Diego , Harvard Medical School , Hospital Heart , Scientific Sessions , California San Diego , Heart Failure , Antiplatelet Agent , Left Ventricular Dysfunction , Antiplatelet Agent Related Bleeding , Ntiplatelet Therapy Related Hemorrhage , Ventricular Assist Device , Echanical Cardiac Assist , Echanical Cardiac Support , Vad Left Ventricle Assist Device , Eft Ventricle Assist Device Lvad , Erebrovascular Accident , Va Cerebrovascular Accide ,

Daily Aspirin Challenged for Preventing First Strokes

The numbers were small, but "numerically, the bleeding events outweighed any possible prevention of ischemic events," said an ASPREE investigator. ....

New York , United States , South Australia , Johnj Mcneil , Us Preventive Services Task , Monash University , Grossman School Of Medicine , Services Task Force , Cardiovascular Disease , Hemorrhagic Stroke , Ischemic Stroke , Stroke Risk , Antiplatelet Agent Related Bleeding , Ntiplatelet Therapy Related Hemorrhage , Cerebrovascular Disease , Clinical Research , Clinical Trials , Linical Studies , Elderly Concerns Of Older Adults , Geriatrics Elder Care ,

Switch to Prasugrel Safe After PCI in East Asian ACS Patients

Dual antiplatelet therapy with prasugrel seemed as safe and effective as primary treatment and as a substitute for other P2Y12 inhibitors in a real-world Korean registry. ....

South Korea , Myocardial Infarction , Acute Coronary Syndrome Acs , Cute Coronary Syndrome , Antiplatelet Agent Related Bleeding , Ntiplatelet Therapy Related Hemorrhage , Percutaneous Coronary Intervention , Antiplatelet Agent ,

USPSTF Final Recommendation on Aspirin for Primary CV Prevention

The Task Force advises against starting aspirin for primary prevention in people aged 60 years or over and suggests the decision should be individualized in those aged 40-59. ....

United States , National Jewish Health , Michael Barry , Andrew Freeman , Allans Brett , Decisions Program , American College Of Cardiology , Journal Of The American Medical Association , Us Preventive Services Task Force , Task Force Statement , Health Decision Sciences Center At Massachusetts , University Of Colorado School Medicine , Us Congress , Agency For Healthcare Research , Services Task Force , American Medical , Task Force , Informed Medical Decisions Program , Health Decision Sciences Center , Massachusetts General Hospital , Medscape Cardiology , Colorado School , Evidence Review , American College , Healthcare Research , Force Statement ,

Rivaroxaban Safely Cuts VTE Risk After COVID-19 Hospitalization

A randomized, open-label trial showed improved clinical outcomes from a low dose of direct oral anticoagulant in patients at high risk for venous thromboembolism and low risk for bleeding. ....

South Australia , Charlotte Bradbury , Zoe Mcquilten , Bayer Janssen , Lixiana Savaysa , Eduardo Ramacciotti , Bristol Myers Squibb , Monash University , Science Valley Research Institute , International Society On Thrombosis , Medscape Coronavirus Resource Center , University Of Bristol , Coronavirus Resource , International Society , 019 Novel Coronavirus , 019 Ncov , Uhan Coronavirus , Uman Coronavirus Hku1 , Uman Coronavirus Oc43 , Cov Oc43 , Uman Coronavirus 229e , Cov 229e , Venous Thromboembolism , Antiplatelet Agent Related Bleeding , Ntiplatelet Therapy Related Hemorrhage , Anticoagulation Therapy ,